HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative T1rho magnetic resonance imaging of RIF-1 tumors in vivo: detection of early response to cyclophosphamide therapy.

Abstract
This study compares two potential magnetic resonance imaging (MRI) indices for noninvasive early detection of tumor response to chemotherapy: the spin-lattice relaxation in the rotating frame (T1rho) and the transverse relaxation time (T2). Measurements of these relaxation parameters were performed on a s.c. murine radiation-induced fibrosarcoma (RIF-1) model before and after cyclophosphamide treatment. The number of pixels exhibiting T1rho values longer than controls in viable regions of the tumor increased significantly as early as 18 h after drug administration and remained elevated up to 36 h after treatment (P < 0.005). Although a trend of increasing T2s relative to controls was noted in viable regions of the tumor 36 h after treatment, the changes were not statistically significant. Histological examination indicated a decrease in mitotic index that paralleled the changes in T1rho. We conclude that T1rho measurements may be useful for noninvasive monitoring of early response of tumors to chemotherapy.
AuthorsU Duvvuri, H Poptani, M Feldman, L Nadal-Desbarats, M S Gee, W M Lee, R Reddy, J S Leigh, J D Glickson
JournalCancer research (Cancer Res) Vol. 61 Issue 21 Pg. 7747-53 (Nov 01 2001) ISSN: 0008-5472 [Print] United States
PMID11691788 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide
Topics
  • Animals
  • Antineoplastic Agents, Alkylating (pharmacology)
  • Cell Division (drug effects)
  • Cell Survival (drug effects)
  • Cyclophosphamide (pharmacology)
  • Dose-Response Relationship, Drug
  • Female
  • Fibrosarcoma (drug therapy, etiology, pathology)
  • Magnetic Resonance Imaging (methods)
  • Mice
  • Mice, Inbred C3H
  • Neoplasms, Radiation-Induced (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: